|
STK17A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.477500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.550360E-02 |
| Normal-vs-Stage2 |
3.57710000000733E-05 |
| Normal-vs-Stage3 |
7.600500E-03 |
| Normal-vs-Stage4 |
2.340400E-03 |
| Stage1-vs-Stage2 |
3.50660000003611E-06 |
| Stage1-vs-Stage3 |
3.978000E-01 |
| Stage1-vs-Stage4 |
1.058570E-01 |
| Stage2-vs-Stage3 |
9.161000E-03 |
| Stage2-vs-Stage4 |
4.817500E-02 |
| Stage3-vs-Stage4 |
5.460000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.981000E-03 |
| Normal-vs-AfricanAmerican |
2.460900E-03 |
| Normal-vs-Asian |
4.698100E-02 |
| Caucasian-vs-AfricanAmerican |
1.892370E-01 |
| Caucasian-vs-Asian |
4.162800E-01 |
| AfricanAmerican-vs-Asian |
1.127560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.878300E-03 |
| Normal-vs-Female |
5.575700E-03 |
| Male-vs-Female |
6.433400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.875900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.750600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.181600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.741000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.619400E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.275400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.160600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.318200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.213400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.113400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.696400E-01 |
| Classical-VS-Follicular |
3.20965476419133E-13 |
| Classical-VS-Other |
1.073050E-01 |
| Classical-VS-Normal |
2.555500E-02 |
| Tall-VS-Follicular |
1.651840E-02 |
| Tall-VS-Other |
9.670300E-02 |
| Tall-VS-Normal |
2.332800E-01 |
| Follicular-VS-Other |
6.116600E-01 |
| Follicular-VS-Normal |
1.61649999996794E-06 |
| Other-VS-Normal |
2.222800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.200500E-04 |
| Normal-vs-N1 |
6.982900E-03 |
| N0-vs-N1 |
3.045800E-01 |
|
|
